In this Masterclass webinar, you'll see remarkable cases of cancer remissions, how the immune system can be a double-edged sword, and the molecular mechanisms of the mind-body connection. Clinical observations and research findings indicate that cancer patients have the ability to directly influence disease outcome.
References
Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12. PMID: 35020204.
https://pubmed.ncbi.nlm.nih.gov/35020204/
Harris TJ, McCormick F. The molecular pathology of cancer. Nat Rev Clin Oncol. 2010 May;7(5):251-65. doi: 10.1038/nrclinonc.2010.41. Epub 2010 Mar 30. PMID: 20351699.
https://pubmed.ncbi.nlm.nih.gov/20351699/
Radha G, Lopus M. The spontaneous remission of cancer: Current insights and therapeutic significance. Transl Oncol. 2021 Sep;14(9):101166. doi: 10.1016/j.tranon.2021.101166. Epub 2021 Jul 6. PMID: 34242964; PMCID: PMC8271173.
https://pubmed.ncbi.nlm.nih.gov/34242964/
Waldman AD, Fritz JM, Lenardo MJ. A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nat Rev Immunol. 2020 Nov;20(11):651-668. doi: 10.1038/s41577-020-0306-5. Epub 2020 May 20. PMID: 32433532; PMCID: PMC7238960.
https://pubmed.ncbi.nlm.nih.gov/32433532/
MacKie RM, Reid R, Junor B. Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery. N Engl J Med. 2003 Feb 6;348(6):567-8. doi: 10.1056/NEJM200302063480620. PMID: 12571271.
https://pubmed.ncbi.nlm.nih.gov/12571271/
Bajaj NS, Watt C, Hadjiliadis D, Gillespie C, Haas AR, Pochettino A, Mendez J, Sterman DH, Schuchter LM, Christie JD, Lee JC, Ahya VN. Donor transmission of malignant melanoma in a lung transplant recipient 32 years after curative resection. Transpl Int. 2010 Jul;23(7):e26-31. doi: 10.1111/j.1432-2277.2010.01090.x. Epub 2010 Apr 28. PMID: 20444242.
https://pubmed.ncbi.nlm.nih.gov/20444242/
Strauss DC, Thomas JM. Transmission of donor melanoma by organ transplantation. Lancet Oncol. 2010 Aug;11(8):790-6. doi: 10.1016/S1470-2045(10)70024-3. Epub 2010 May 5. PMID: 20451456.
https://pubmed.ncbi.nlm.nih.gov/20451456/
Suntharalingam G, Perry MR, Ward S, Brett SJ, Castello-Cortes A, Brunner MD, Panoskaltsis N. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med. 2006 Sep 7;355(10):1018-28. doi: 10.1056/NEJMoa063842. Epub 2006 Aug 14. PMID: 16908486.
https://pubmed.ncbi.nlm.nih.gov/16908486/
Sen DR, Kaminski J, Barnitz RA, Kurachi M, Gerdemann U, Yates KB, Tsao HW, Godec J, LaFleur MW, Brown FD, Tonnerre P, Chung RT, Tully DC, Allen TM, Frahm N, Lauer GM, Wherry EJ, Yosef N, Haining WN. The epigenetic landscape of T cell exhaustion. Science. 2016 Dec 2;354(6316):1165-1169. doi: 10.1126/science.aae0491. Epub 2016 Oct 27. PMID: 27789799; PMCID: PMC5497589.
https://pubmed.ncbi.nlm.nih.gov/27789799/
Franco F, Jaccard A, Romero P, Yu YR, Ho PC. Metabolic and epigenetic regulation of T-cell exhaustion. Nat Metab. 2020 Oct;2(10):1001-1012. doi: 10.1038/s42255-020-00280-9. Epub 2020 Sep 21. PMID: 32958939.
https://pubmed.ncbi.nlm.nih.gov/32958939/
de Magalhães JP. How ageing processes influence cancer. Nat Rev Cancer. 2013 May;13(5):357-65. doi: 10.1038/nrc3497. PMID: 23612461.
https://pubmed.ncbi.nlm.nih.gov/23612461/
Radha G, Lopus M. The spontaneous remission of cancer: Current insights and therapeutic significance. Transl Oncol. 2021 Sep;14(9):101166. doi: 10.1016/j.tranon.2021.101166. Epub 2021 Jul 6. PMID: 34242964; PMCID: PMC8271173.
https://pubmed.ncbi.nlm.nih.gov/34242964/
Vernon LF. William Bradley Coley, MD, and the phenomenon of spontaneous regression. Immunotargets Ther. 2018 Apr 23;7:29-34. doi: 10.2147/ITT.S163924. PMID: 29719818; PMCID: PMC5922243.
https://pubmed.ncbi.nlm.nih.gov/29719818/
Sousa LG, McGrail DJ, Li K, Marques-Piubelli ML, Gonzalez C, Dai H, Ferri-Borgogno S, Godoy M, Burks J, Lin SY, Bell D, Ferrarotto R. Spontaneous tumor regression following COVID-19 vaccination. J Immunother Cancer. 2022 Mar;10(3):e004371. doi: 10.1136/jitc-2021-004371. PMID: 35241495; PMCID: PMC8896046.
https://pubmed.ncbi.nlm.nih.gov/35241495/
Buchler T, Fiser L, Benesova J, Jirickova H, Votrubova J. Spontaneous Regression of Metastatic Renal Cell Carcinoma after SARS-CoV-2 Infection: A Report of Two Cases. Curr Oncol. 2021 Sep 3;28(5):3403-3407. doi: 10.3390/curroncol28050294. PMID: 34590589; PMCID: PMC8482236.
https://pubmed.ncbi.nlm.nih.gov/34590589/
Ooi KH, Cheo T, Soon GST, Leong CN. Spontaneous regression of locally advanced nonsmall cell lung cancer: A case report. Medicine (Baltimore). 2018 Aug;97(31):e11291. doi: 10.1097/MD.0000000000011291. PMID: 30075496; PMCID: PMC6081199.
https://pubmed.ncbi.nlm.nih.gov/30075496/
Hicks AM, Riedlinger G, Willingham MC, Alexander-Miller MA, Von Kap-Herr C, Pettenati MJ, Sanders AM, Weir HM, Du W, Kim J, Simpson AJ, Old LJ, Cui Z. Transferable anticancer innate immunity in spontaneous regression/complete resistance mice. Proc Natl Acad Sci U S A. 2006 May 16;103(20):7753-8. doi: 10.1073/pnas.0602382103. Epub 2006 May 8. PMID: 16682640; PMCID: PMC1458507.
https://pubmed.ncbi.nlm.nih.gov/16682640/
Esfahani K, Roudaia L, Buhlaiga N, Del Rincon SV, Papneja N, Miller WH Jr. A review of cancer immunotherapy: from the past, to the present, to the future. Curr Oncol. 2020 Apr;27(Suppl 2):S87-S97. doi: 10.3747/co.27.5223. Epub 2020 Apr 1. PMID: 32368178; PMCID: PMC7194005.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194005/
Sharma P, Allison JP. Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential. Cell. 2015 Apr 9;161(2):205-14. doi: 10.1016/j.cell.2015.03.030. PMID: 25860605; PMCID: PMC5905674.
https://pubmed.ncbi.nlm.nih.gov/25860605/
Waldman AD, Fritz JM, Lenardo MJ. A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nat Rev Immunol. 2020 Nov;20(11):651-668. doi: 10.1038/s41577-020-0306-5. Epub 2020 May 20. PMID: 32433532; PMCID: PMC7238960.
https://pubmed.ncbi.nlm.nih.gov/32433532/
Fares CM, Van Allen EM, Drake CG, Allison JP, Hu-Lieskovan S. Mechanisms of Resistance to Immune Checkpoint Blockade: Why Does Checkpoint Inhibitor Immunotherapy Not Work for All Patients? Am Soc Clin Oncol Educ Book. 2019 Jan;39:147-164. doi: 10.1200/EDBK_240837. Epub 2019 May 17. PMID: 31099674.
https://pubmed.ncbi.nlm.nih.gov/31099674/
Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman K, Wei SC, Cogdill AP, Zhao L, Hudgens CW, Hutchinson DS, Manzo T, Petaccia de Macedo M, Cotechini T, Kumar T, Chen WS, Reddy SM, Szczepaniak Sloane R, Galloway-Pena J, Jiang H, Chen PL, Shpall EJ, Rezvani K, Alousi AM, Chemaly RF, Shelburne S, Vence LM, Okhuysen PC, Jensen VB, Swennes AG, McAllister F, Marcelo Riquelme Sanchez E, Zhang Y, Le Chatelier E, Zitvogel L, Pons N, Austin-Breneman JL, Haydu LE, Burton EM, Gardner JM, Sirmans E, Hu J, Lazar AJ, Tsujikawa T, Diab A, Tawbi H, Glitza IC, Hwu WJ, Patel SP, Woodman SE, Amaria RN, Davies MA, Gershenwald JE, Hwu P, Lee JE, Zhang J, Coussens LM, Cooper ZA, Futreal PA, Daniel CR, Ajami NJ, Petrosino JF, Tetzlaff MT, Sharma P, Allison JP, Jenq RR, Wargo JA. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science. 2018 Jan 5;359(6371):97-103. doi: 10.1126/science.aan4236. Epub 2017 Nov 2. PMID: 29097493; PMCID: PMC5827966.
https://pubmed.ncbi.nlm.nih.gov/29097493/
Spencer CN, McQuade JL, Gopalakrishnan V, McCulloch JA, Vetizou M, Cogdill AP, Khan MAW, Zhang X, White MG, Peterson CB, Wong MC, Morad G, Rodgers T, Badger JH, Helmink BA, Andrews MC, Rodrigues RR, Morgun A, Kim YS, Roszik J, Hoffman KL, Zheng J, Zhou Y, Medik YB, Kahn LM, Johnson S, Hudgens CW, Wani K, Gaudreau PO, Harris AL, Jamal MA, Baruch EN, Perez-Guijarro E, Day CP, Merlino G, Pazdrak B, Lochmann BS, Szczepaniak-Sloane RA, Arora R, Anderson J, Zobniw CM, Posada E, Sirmans E, Simon J, Haydu LE, Burton EM, Wang L, Dang M, Clise-Dwyer K, Schneider S, Chapman T, Anang NAS, Duncan S, Toker J, Malke JC, Glitza IC, Amaria RN, Tawbi HA, Diab A, Wong MK, Patel SP, Woodman SE, Davies MA, Ross MI, Gershenwald JE, Lee JE, Hwu P, Jensen V, Samuels Y, Straussman R, Ajami NJ, Nelson KC, Nezi L, Petrosino JF, Futreal PA, Lazar AJ, Hu J, Jenq RR, Tetzlaff MT, Yan Y, Garrett WS, Huttenhower C, Sharma P, Watowich SS, Allison JP, Cohen L, Trinchieri G, Daniel CR, Wargo JA. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response. Science. 2021 Dec 24;374(6575):1632-1640. doi: 10.1126/science.aaz7015. Epub 2021 Dec 23. PMID: 34941392; PMCID: PMC8970537.
https://pubmed.ncbi.nlm.nih.gov/34941392/
Baruch EN, Youngster I, Ben-Betzalel G, Ortenberg R, Lahat A, Katz L, Adler K, Dick-Necula D, Raskin S, Bloch N, Rotin D, Anafi L, Avivi C, Melnichenko J, Steinberg-Silman Y, Mamtani R, Harati H, Asher N, Shapira-Frommer R, Brosh-Nissimov T, Eshet Y, Ben-Simon S, Ziv O, Khan MAW, Amit M, Ajami NJ, Barshack I, Schachter J, Wargo JA, Koren O, Markel G, Boursi B. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. Science. 2021 Feb 5;371(6529):602-609. doi: 10.1126/science.abb5920. Epub 2020 Dec 10. PMID: 33303685.
https://pubmed.ncbi.nlm.nih.gov/33303685/
Sepich-Poore GD, Zitvogel L, Straussman R, Hasty J, Wargo JA, Knight R. The microbiome and human cancer. Science. 2021 Mar 26;371(6536):eabc4552. doi: 10.1126/science.abc4552. PMID: 33766858; PMCID: PMC8767999.
https://pubmed.ncbi.nlm.nih.gov/33766858/
Helmink BA, Khan MAW, Hermann A, Gopalakrishnan V, Wargo JA. The microbiome, cancer, and cancer therapy. Nat Med. 2019 Mar;25(3):377-388. doi: 10.1038/s41591-019-0377-7. Epub 2019 Mar 6. PMID: 30842679.
https://pubmed.ncbi.nlm.nih.gov/30842679/
Champiat S, Ferrara R, Massard C, Besse B, Marabelle A, Soria JC, Ferté C. Hyperprogressive disease: recognizing a novel pattern to improve patient management. Nat Rev Clin Oncol. 2018 Dec;15(12):748-762. doi: 10.1038/s41571-018-0111-2. PMID: 30361681.
https://pubmed.ncbi.nlm.nih.gov/30361681/
Park HJ, Kim KW, Won SE, Yoon S, Chae YK, Tirumani SH, Ramaiya NH. Definition, Incidence, and Challenges for Assessment of Hyperprogressive Disease During Cancer Treatment With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis. JAMA Netw Open. 2021 Mar 1;4(3):e211136. doi: 10.1001/jamanetworkopen.2021.1136. PMID: 33760090; PMCID: PMC7991969.
https://pubmed.ncbi.nlm.nih.gov/33760090/
Scheff NN, Saloman JL. Neuroimmunology of cancer and associated symptomology. Immunol Cell Biol. 2021 Oct;99(9):949-961. doi: 10.1111/imcb.12496. Epub 2021 Sep 12. PMID: 34355434; PMCID: PMC9250294.
https://pubmed.ncbi.nlm.nih.gov/34355434/
Shurin MR, Shurin GV, Zlotnikov SB, Bunimovich YL. The Neuroimmune Axis in the Tumor Microenvironment. J Immunol. 2020 Jan 15;204(2):280-285. doi: 10.4049/jimmunol.1900828. PMID: 31907270.
https://pubmed.ncbi.nlm.nih.gov/31907270/
Visintainer MA, Volpicelli JR, Seligman ME. Tumor rejection in rats after inescapable or escapable shock. Science. 1982 Apr 23;216(4544):437-9. doi: 10.1126/science.7200261. PMID: 7200261.
https://pubmed.ncbi.nlm.nih.gov/7200261/
Laudenslager ML, Ryan SM, Drugan RC, Hyson RL, Maier SF. Coping and immunosuppression: inescapable but not escapable shock suppresses lymphocyte proliferation. Science. 1983 Aug 5;221(4610):568-70. doi: 10.1126/science.6603018. PMID: 6603018.
https://pubmed.ncbi.nlm.nih.gov/6603018/
Eckerling A, Ricon-Becker I, Sorski L, Sandbank E, Ben-Eliyahu S. Stress and cancer: mechanisms, significance and future directions. Nat Rev Cancer. 2021 Dec;21(12):767-785. doi: 10.1038/s41568-021-00395-5. Epub 2021 Sep 10. PMID: 34508247.
https://pubmed.ncbi.nlm.nih.gov/34508247/
Alves de Lima K, Rustenhoven J, Da Mesquita S, Wall M, Salvador AF, Smirnov I, Martelossi Cebinelli G, Mamuladze T, Baker W, Papadopoulos Z, Lopes MB, Cao WS, Xie XS, Herz J, Kipnis J. Meningeal γδ T cells regulate anxiety-like behavior via IL-17a signaling in neurons. Nat Immunol. 2020 Nov;21(11):1421-1429. doi: 10.1038/s41590-020-0776-4. Epub 2020 Sep 14. PMID: 32929273; PMCID: PMC8496952.
https://pubmed.ncbi.nlm.nih.gov/32929273/
Perego M, Tyurin VA, Tyurina YY, Yellets J, Nacarelli T, Lin C, Nefedova Y, Kossenkov A, Liu Q, Sreedhar S, Pass H, Roth J, Vogl T, Feldser D, Zhang R, Kagan VE, Gabrilovich DI. Reactivation of dormant tumor cells by modified lipids derived from stress-activated neutrophils. Sci Transl Med. 2020 Dec 2;12(572):eabb5817. doi: 10.1126/scitranslmed.abb5817. PMID: 33268511; PMCID: PMC8085740.
https://pubmed.ncbi.nlm.nih.gov/33268511/
Gibson EM, Nagaraja S, Ocampo A, Tam LT, Wood LS, Pallegar PN, Greene JJ, Geraghty AC, Goldstein AK, Ni L, Woo PJ, Barres BA, Liddelow S, Vogel H, Monje M. Methotrexate Chemotherapy Induces Persistent Tri-glial Dysregulation that Underlies Chemotherapy-Related Cognitive Impairment. Cell. 2019 Jan 10;176(1-2):43-55.e13. doi: 10.1016/j.cell.2018.10.049. Epub 2018 Dec 6. PMID: 30528430; PMCID: PMC6329664.
https://pubmed.ncbi.nlm.nih.gov/30528430/
Horky LL, Gerbaudo VH, Zaitsev A, Plesniak W, Hainer J, Govindarajulu U, Kikinis R, Dietrich J. Systemic chemotherapy decreases brain glucose metabolism. Ann Clin Transl Neurol. 2014 Oct;1(10):788-98. doi: 10.1002/acn3.121. Epub 2014 Oct 1. PMID: 25493270; PMCID: PMC4241806.
https://pubmed.ncbi.nlm.nih.gov/25493270/
Lee DY. Cancer Epigenomics and Beyond: Advancing the Precision Oncology Paradigm. J Immunother Precis Oncol. 2020 Oct 7;3(4):147-156. doi: 10.36401/JIPO-20-18. Erratum in: J Immunother Precis Oncol. 2022 Aug 30;5(4):161. PMID: 35665374; PMCID: PMC9165444.
https://pubmed.ncbi.nlm.nih.gov/35665374/
